CureAccelerator Live! for Pediatric Rare Diseases

Funding Agency:
Cures Within Reach

This Request for Proposals (RFP) from Cures Within Reach is seeking clinical trials using repurposed treatments for any rare pediatric disease for an upcoming CureAccelerator Live! event. CureAccelerator Live! is a philanthropic pitch event, raising awareness of and funding for innovative repurposing research projects, with up to $50,000 funding for the winning project announced that evening. This RFP seeks clinical repurposing trials, up to five of which will be selected to pitch at this live event, held virtually on June 10-11, 2021. More details about the event to come.

This CureAccelerator Live! will showcase clinical repurposing trials in pediatric rare diseases. A rare disease is defined by US standards as a condition that impacts fewer than 200,000 people, or by European standards as a condition than impacts less than 1 in 2,000 people. Eligible submissions can come from anywhere, with a preference for US-based institutions.

Repurposing research tests already approved and available therapies to determine if they are safe and effective in treating a different indication, thereby improving patient outcomes and quality of life. Repurposed therapies can be used alone or in combination with other therapies. Therapies must already be FDA, EMA or any other regulatory agency approved or otherwise readily available for human use.

Deadline: March 17, 2021

Agency Website



Amount Description

Cures Within Reach will provide no more than 80% of the REQUESTED PROJECT FUNDING, and the institution, organization or company proposing the research will match at least 20% of the REQUESTED PROJECT FUNDING. The REQUESTED PROJECT FUNDING is equal to the ESTIMATED OVERALL PROJECT COSTS in the BUDGET BREAKDOWN section of the proposal submission, and includes the 20% Institutional Match. The 20% Institutional Match must be real dollars committed to the project, not inkind efforts, and can include Indirect Costs. The Institutional Match can come from the Research Institution itself (including salaries, patient costs, etc.); from government or other public funders; from individuals, foundations or other private funders; or from any combination of these sources.

Funding Type





Medical - Clinical Science
Medical - Translational

External Deadline

March 17, 2021